Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsNASDAQFinancialsFinancial - Data & Stock ExchangesSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Free cash flow yield stays near 5% | The company generates free cash flow with a yield of 5%. | Under Pressure | Free cash flow yield falls below 5% | Free cash flow yield: 4.38% As of 2026-10-23; trailing twelve months. The target timing and basis require a separate assessment. Market data as of Oct 23, 20264.38 percent · calculatedLast status assessment Oct 24, 2026Measurement sourceconsolidated · TTM valuation Period ending Oct 23, 2026 Source: mart.stock_valuation_daily. Reference: VALU:2026-10-23. Source status: canonical calculation. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a smaller-cap Financials name with a weak recent performance profile, rather than a clear durable compounder today. Management is rated stable, but the long-term thesis remains in a watch state because results trail the industry cohort and execution quality is flagged as weak.
VALU is valued at a sizable premium versus peers, and the evidence flags that premium as difficult to justify given weak execution. The valuation measure has fallen recently, but the expectations gap remains notable and confidence in the assessment is medium.
Near term, consecutive earnings misses and the smaller company size raise the risk of another miss; recent financial performance is rated weak. Over the multi-year view, stable management is a support, but the evidence does not yet show a clear improvement in execution or results.
The near-term sector backdrop may weaken if the Federal Reserve starts cutting rates, while continued earnings strength from sector bellwethers could sustain support for Financials. Misses or lower guidance from those bellwethers could remove that support, and VALU’s own ability to improve execution remains a key swing factor.
Over the next one to three years, the thesis depends on better company execution and a supportive Financials backdrop, while the current peer premium leaves limited room for weak results. Evidence is mixed, so the long-term thesis remains in a watch state. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Maintain profit margins near current levels | A primary condition in Value Line, Inc.'s published investment case. The stated target is Maintain profit margin near current TTM levels. | Broken | Profit margin declines significantly below recent TTM levels | Net margin: 57.82% FY2027-Q1; GAAP. Published target: Maintain profit margin near current TTM levels. Target percentage unit is not explicit. Source published Sep 14, 202657.818904 percent · calculatedSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2027-Q1 · Period ending Jul 31, 2026 Source: company_financial_results. Reference: 27ea0bef-26bc-41f0-9de0-db44a59dd2fb. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth remains above -5% annually | A primary condition in Value Line, Inc.'s published investment case. The stated target is >= -5% YoY revenue growth. | Intact | YoY revenue growth falls below -5% next year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.